share_log

藥明巨諾-B：建議發行股份、自庫存轉撥股份及購回股份的一般授權及重選董事及重新委任核數師及採納新組織章程大綱及細則及股東週年大會通告

JW THERAP-B: PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES, TRANSFER SHARES OUT OF TREASURY AND REPURCHASE SHARES AND RE-ELECTION OF DIRECTORS AND RE-APPOINTMENT OF AUDITOR AND ADOPTION OF NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING

Hong Kong Stock Exchange ·  Apr 25 18:48
Summary by Moomoo AI
藥明巨諾-B（股份代號：2126）將於2024年6月18日上午十時在中國上海浦東新區中科路699號B棟5層展示廳會議室召開股東週年大會。會議將處理包括接收及採納截至2023年12月31日止年度經審核綜合財務報表、董事會報告及核數師報告，重選董事，續聘羅兵咸永道會計師事務所為核數師，以及授予發行股份、自庫存轉撥股份及購回股份的一般授權等事項。此外，將提呈特別決議案以採納新組織章程大綱及細則。股東將於2024年6月13日至18日暫停辦理股份過戶登記，以確定出席大會的資格。董事會已聲明，目前無即時計劃發行新股份，並將在適當情況下行使購回股份的權力。
藥明巨諾-B（股份代號：2126）將於2024年6月18日上午十時在中國上海浦東新區中科路699號B棟5層展示廳會議室召開股東週年大會。會議將處理包括接收及採納截至2023年12月31日止年度經審核綜合財務報表、董事會報告及核數師報告，重選董事，續聘羅兵咸永道會計師事務所為核數師，以及授予發行股份、自庫存轉撥股份及購回股份的一般授權等事項。此外，將提呈特別決議案以採納新組織章程大綱及細則。股東將於2024年6月13日至18日暫停辦理股份過戶登記，以確定出席大會的資格。董事會已聲明，目前無即時計劃發行新股份，並將在適當情況下行使購回股份的權力。
Yauming Jelno-B (Stock Code: 2126) will hold its Annual General Meeting on 18 June 2024 at 10:00am in the Conference Room, 5-Floor Exhibition Hall B, 699 Zhongco Road, Pudong New District, Shanghai, China. The meeting will cover the receipt and adoption of the audited consolidated financial statements for the year ended 31 December 2023, Board reports and auditor's reports, re-election of directors, renewal of the Board of Accountants of Robinham Wing Road as auditor, and the granting of general mandates to issue shares, transfer of shares from stock and repurchase of shares, etc. Matters. In addition, a special resolution will be tabled to adopt the new articles of association and rules. Shareholders will suspend registration of shares from 13 to 18 June 2024 to determine their eligibility to attend the General Meeting. The Board has stated that there are no immediate plans to issue new shares at this time and will exercise the power to repurchase the shares as appropriate.
Yauming Jelno-B (Stock Code: 2126) will hold its Annual General Meeting on 18 June 2024 at 10:00am in the Conference Room, 5-Floor Exhibition Hall B, 699 Zhongco Road, Pudong New District, Shanghai, China. The meeting will cover the receipt and adoption of the audited consolidated financial statements for the year ended 31 December 2023, Board reports and auditor's reports, re-election of directors, renewal of the Board of Accountants of Robinham Wing Road as auditor, and the granting of general mandates to issue shares, transfer of shares from stock and repurchase of shares, etc. Matters. In addition, a special resolution will be tabled to adopt the new articles of association and rules. Shareholders will suspend registration of shares from 13 to 18 June 2024 to determine their eligibility to attend the General Meeting. The Board has stated that there are no immediate plans to issue new shares at this time and will exercise the power to repurchase the shares as appropriate.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more